Compare SUPN & SYBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SUPN | SYBT |
|---|---|---|
| Founded | 2005 | 1904 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.4B |
| IPO Year | 2014 | 2009 |
| Metric | SUPN | SYBT |
|---|---|---|
| Price | $29.57 | $79.01 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 6 |
| Target Price | $54.14 | ★ $87.60 |
| AVG Volume (30 Days) | ★ 2.4M | 123.0K |
| Earning Date | 10-29-2026 | 10-28-2026 |
| Dividend Yield | N/A | ★ 1.67% |
| EPS Growth | ★ 8100.00 | 22.11 |
| EPS | 2.78 | ★ 3.95 |
| Revenue | ★ $1,239,000,000.00 | $23,406,000.00 |
| Revenue This Year | $51.56 | $15.69 |
| Revenue Next Year | $30.35 | $9.90 |
| P/E Ratio | ★ $10.65 | $19.96 |
| Revenue Growth | ★ 4.29 | 3.37 |
| 52 Week Low | $25.92 | $61.51 |
| 52 Week High | $59.68 | $89.22 |
| Indicator | SUPN | SYBT |
|---|---|---|
| Relative Strength Index (RSI) | 31.65 | 49.36 |
| Support Level | $25.92 | $75.81 |
| Resistance Level | $51.59 | $78.73 |
| Average True Range (ATR) | 2.00 | 1.77 |
| MACD | -0.52 | -0.03 |
| Stochastic Oscillator | 19.96 | 34.70 |
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.
Stock Yards Bancorp Inc operates as a bank holding company providing commercial banking and wealth management services. Its Commercial Banking segment offers loan and deposit products to consumers and businesses, including retail and mortgage lending, deposit services, online and mobile banking, private banking, commercial and real estate lending, treasury and merchant services, international and correspondent banking, credit cards, and brokerage services through a third-party broker-dealer. Its Wealth Management and Trust (WM&T) segment provides investment management, financial and retirement planning, trust and estate services, and retirement plan management, with WM&T revenue distinguishing the company from similarly sized community banks.